These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10919259)
21. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity. Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662 [TBL] [Abstract][Full Text] [Related]
22. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. Suarez-Pinzon WL; Mabley JG; Strynadka K; Power RF; Szabó C; Rabinovitch A J Autoimmun; 2001 Jun; 16(4):449-55. PubMed ID: 11437493 [TBL] [Abstract][Full Text] [Related]
23. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice. Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360 [TBL] [Abstract][Full Text] [Related]
24. Arginase increases total pancreatic and islet blood flow in anaesthetized mice. Jansson L; Bodin B; Källskog O Ups J Med Sci; 2007; 112(2):165-73. PubMed ID: 17578816 [TBL] [Abstract][Full Text] [Related]
25. Vascular reactivity in arterioles from normal and alloxan-diabetic mice: studies on single perfused islets. Lai EY; Jansson L; Patzak A; Persson AE Diabetes; 2007 Jan; 56(1):107-12. PubMed ID: 17192471 [TBL] [Abstract][Full Text] [Related]
27. Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice. Papaccio G; Esposito V; Latronico MV; Pisanti FA Int J Pancreatol; 1995 Feb; 17(1):63-8. PubMed ID: 8568336 [TBL] [Abstract][Full Text] [Related]
28. Endothelial nitric oxide synthase is protective in the initiation of caerulein-induced acute pancreatitis in mice. DiMagno MJ; Williams JA; Hao Y; Ernst SA; Owyang C Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G80-7. PubMed ID: 14962849 [TBL] [Abstract][Full Text] [Related]
29. Hypoglycaemia induces decreased islet blood perfusion mediated by the central nervous system in normal and Type 2 diabetic GK rats. Carlsson PO; Berne C; Ostenson CG; Andersson A; Jansson L Diabetologia; 2003 Aug; 46(8):1124-30. PubMed ID: 12830382 [TBL] [Abstract][Full Text] [Related]
30. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018 [TBL] [Abstract][Full Text] [Related]
31. Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production. Stosić-Grujicić S; Maksimović D; Badovinac V; Samardzić T; Trajković V; Lukić M; Mostarica Stojković M J Autoimmun; 2001 Feb; 16(1):47-58. PubMed ID: 11221996 [TBL] [Abstract][Full Text] [Related]
32. Development of low-dose streptozotocin-induced diabetes in ICAM-1-deficient mice. Martin S; Vinke A; Heidenthal E; Schulte B; van den Engel N Horm Metab Res; 1999 Dec; 31(12):636-40. PubMed ID: 10668914 [TBL] [Abstract][Full Text] [Related]
33. Pancreatic islet blood flow in normal and obese-hyperglycemic (ob/ob) mice. Carlsson PO; Andersson A; Jansson L Am J Physiol; 1996 Dec; 271(6 Pt 1):E990-5. PubMed ID: 8997216 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic islet circulation in relation to the diabetogenic action of streptozotocin in the rat. Jansson L; Sandler S Endocrinology; 1985 Mar; 116(3):896-900. PubMed ID: 3156031 [TBL] [Abstract][Full Text] [Related]
36. A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Bonnevie-Nielsen V; Steffes MW; Lernmark A Diabetes; 1981 May; 30(5):424-9. PubMed ID: 6453032 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Lukic ML; Stosic-Grujicic S; Ostojic N; Chan WL; Liew FY Biochem Biophys Res Commun; 1991 Aug; 178(3):913-20. PubMed ID: 1831356 [TBL] [Abstract][Full Text] [Related]
38. Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes. Stosic-Grujicic S; Dimitrijevic M; Bartlett R Clin Exp Immunol; 1999 Jul; 117(1):44-50. PubMed ID: 10403914 [TBL] [Abstract][Full Text] [Related]
39. Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse. Sandler S Diabetologia; 1984 May; 26(5):386-8. PubMed ID: 6234194 [TBL] [Abstract][Full Text] [Related]
40. Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. Li Z; Karlsson FA; Sandler S J Endocrinol; 2000 Apr; 165(1):93-9. PubMed ID: 10750039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]